Evidence map›Paper›PMID 35482832›Full record

ReviewCirculation research2022

Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.

Evan L Brittain, Anna R Hemnes

Abstract readReview
In one paragraph

Review in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Evan L BrittainVanderbilt University Medical Center, Nashville, TN.
Anna R HemnesVanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-2755-5845

Funding

Sex Hormones in Pulmonary Arterial HypertensionP01HL108800 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NEWMAN, JOHN HUGHES · 2012 to 2021
$22.0M
Genomic and Circulating Predictors of PAH responseR01HL142720 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Anna R Hemnes · 2019 to 2026
$5.0M
Effect of PDE5 Inhibition on Adipose Metabolism in HumansR01DK124845 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BRITTAIN, EVAN L, DAMON, BRUCE M. · 2021 to 2025
$3.4M
Clinical, Genetic, and Proteomic Risk Factors for Pulmonary Hypertension in Heart FailureR01HL146588 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BRITTAIN, EVAN L, FREIBERG, MATTHEW S · 2019 to 2022
$3.4M
A molecular phenotype of combined pulmonary hypertensionU01HL125212 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEMNES, ANNA R, NEWMAN, JOHN HUGHES · 2014 to 2018
$1.5M
NHLBI NIH HHS P01 HL108800NHLBI NIH HHS R01 HL142720NHLBI NIH HHS R01 HL146588NHLBI NIH HHS U01 HL125212NIDDK NIH HHS R01 DK124845
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heart FailureVascular DiseasesHeart VentriclesHumansLungPulmonary CirculationcathetersEditorialsheart ventricleslungnobel prizepulmonary hypertension

Identifiers

PMID35482832
PMCPMC9899118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.